SecBot SecBot
Insider Cluster (2 insiders) ·Filed Sep 3, 2026

TARS

Tarsus Pharmaceuticals, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago
Insider cluster: 2 insiders, $928K total
Actionable Insight • Neutral

Insider selling is minimal relative to market cap and likely reflects routine portfolio diversification or tax planning. No bearish read-through. Monitor upcoming earnings or pipeline catalysts for real signals.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$90.78
T+0 close · Sep 3, 2026 · via day close
Latest settled
−17.98%
T+20 · $74.46 · next T+60 in 14d
Vs SPY
−18.84%
α at T+20
Latest observation
−6.81%
T+50 · FF3 residual α
  1. T+0 · Sep 4 $90.78entry
  2. T+1 · 2mo ago −3.92%α −3.37% · $87.22
  3. T+5 · 2mo ago −11.93%α −10.72% · $79.95
  4. T+20 · 6w ago −17.98%α −18.84% · $74.46
  5. T+50 · todayOpen
  6. T+60 · in 14d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CEO Bobak Azamian and CMO Elizabeth Yeu sold a combined $928K in TARS shares over two days. The total represents just 0.026% of the company's $3.6B market cap, a trivial amount that is routine and non-informative. No bearish signal is warranted from this cluster.

Key Financial Metrics

Direction
selling
Total Value
$928.0K
Insiders
2

Key Facts

  • CEO Bobak Azamian sold 10,000 shares at $80.06 for $801K on 2026-09-02.
  • CMO Elizabeth Yeu sold 1,590 shares at $80.00 for $127K on 2026-09-02.
  • Total cluster value of $928K is only 0.026% of TARS's $3.6B market cap.
  • Insider sells are weak predictors per academic literature, especially at this size.

Financial Impact

Negligible, $928K is 0.026% of market cap, well below the 0.1% materiality threshold.

Risk Factors

  • No material risk from this filing; the selling is too small to indicate insider concern.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (15 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-TARS-1788506906577

Track record

21 reports on TARS

Performance horizon

5 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +27.36% at T+20 after the Aug 6, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 13, 20263d ago 144 Neutral 2/10 Entry $76.56 Now $78.68 +2.78% settles Nov 23
  2. Nov 5, 202611d ago 3 Neutral 2/10 Entry $68.60 to $80.28 Now $78.68 +14.69% ▲ +17.03% +14.43% vs SPY
  3. Nov 5, 202611d ago SC 13G Neutral 3/10 Entry $67.52 to $76.89 Now $78.68 +16.53% ▲ +13.88% +10.59% vs SPY
  4. Nov 3, 202613d ago 8-K Neutral 5/10 No price data
  5. Nov 3, 202613d ago Press Release Neutral 5/10 Entry $69.07 to $76.76 Now $78.68 +13.91% ▲ +11.13% +12.05% vs SPY
  6. Oct 16, 20264w ago Institutional Cluster Bullish 4/10 Entry $69.50 to $70.03 Now $78.68 +13.21% ▲ +0.76% +0.91% vs SPY
  7. Oct 13, 20264w ago S-3ASR Neutral 4/10 Entry $72.29 to $70.50 Now $78.68 +8.84% ▼ −2.48% −2.93% vs SPY
  8. Oct 13, 20264w ago S-3ASR Neutral 3/10 Entry $72.29 to $70.50 Now $78.68 +8.84% ▼ −2.48% −2.93% vs SPY
  9. Sep 9, 20269w ago Insider Cluster Neutral 3/10 Entry $81.12 to $79.03 Now $78.68 −3.01% ▼ −2.58% −3.21% vs SPY
  10. Sep 3, 202610w ago Insider Cluster Neutral 2/10 Viewing Entry $90.78 to $79.95 Now $78.68 −13.33% ▼ −11.93% −10.72% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens in 6h 42m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 4, 2026